2025 Subject Index
PDF
Cite
Share
Request
Index
VOLUME: 11 ISSUE: 3
P: 217 - 217
November 2025

2025 Subject Index

Nucl Med Semin 2025;11(3):217-217
No information available.
No information available
PDF
Cite
Share
Request
131-I
active dosimeter
adrenal gland
bone
bone marrow dosimetry
brain perfusion SPECT
contamination
diuretic scintigraphy
dosimetry
1 ,
6
dosimetry of benign thyroid diseases
1
dosimetry on I-131 treatment
effective dose
electrometer
endocrine diseases
epilepsy
FDG PET
FDG PET/CT
Fever of unknown origin
gastric emptying scintigraphy
gastroesophageal reflux
gastrointestinal bleeding
health physicist
hepatobiliary system scintigraphy
Lesion dosimetry
Lu-177 dosimetry
Lu-177 PSMA-targeted ligands
Lu-177 somatostatin receptor ligands
Meckel diverticulum
medical physicist
mosfet
myocardial perfusion
neuroendocrine tumors
occupational health
OSL
parathyroid
Pediatric
pediatric cardiology
pediatric hydronephrosis
Pediatric neurology
Pediatric nuclear medicine
Pediatrics
Personal dosimeter
PET/CT
81 ,
prostate adenocarcinoma
public health
pulmonary scintigraphy
radiation protection
21 ,
Radiation safety culture
Radioactive treatment
radioiodine therapy
11 ,
6
Radioiodine treatment
radionuclide imaging
radiopharmacist
Remnant tissue dosimetry
6
renal cortical scintigraphy
Renography
Roles and responsibilities
Scintigraphy
SPECT
Tc-99m DMSA
technologist
thyroid
TLD
Treatment of hyperthyroidism
1
tumor dosimetry in I-131 treatment
urologic disorders
Y-90 dosimetry
Y-90 microsphere dosimetry
Y-90 radioembolization treatment dosimetry